The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Autism: Metabolism, Mitochondria, and the Microbiome
Open accessAbstract
New approaches are needed to examine the diverse symptoms and comorbidities of the growing family of neurodevelopmental disorders known as autism spectrum disorder (ASD). ASD originally was thought to be a static, inheritable neurodevelopmental disorder, and our understanding of it is undergoing a major shift. It is emerging as a dynamic system of metabolic and immune anomalies involving many organ systems, including the brain, and environmental exposure. The initial detailed observation and inquiry of patients with ASD and related conditions and the histories of their care-givers and families have been invaluable. How gastrointestinal (GI) factors are related to ASD is not yet clear. Nevertheless, many patients with ASD have a history of previous antibiotic exposure or hospitalization, GI symptoms, abnormal food cravings, and unique intestinal bacterial populations, which have been proposed to relate to variable symptom severity. In addition to traditional scientific inquiry, detailed clinical observation and recording of exacerbations, remissions, and comorbidities are needed. This article reviews the role that enteric short-chain fatty acids, particularly propionic (also called propanoic) acid, produced from ASD-associated GI bacteria, may play in the etiology of some forms of ASD. Human populations that are partial metabolizers of propionic acid are more common than previously thought. The results from pre-clinical laboratory studies show that propionic acid-treated rats display ASD-like repetitive, perseverative, and antisocial behaviors and seizure. Neurochemical changes, consistent and predictive with findings in ASD patients, including neuroinflammation, increased oxidative stress, mitochondrial dysfunction, glutathione depletion, and altered phospholipid/acylcarnitine profiles, have been observed. Propionic acid has bioactive effects on (1) neurotransmitter systems, (2) intracellular acidification and calcium release, (3) fatty acid metabolism, (4) gap junction gating, (5) immune function, and (6) alteration of gene expression that warrant further exploration. Traditional scientific experimentation is needed to verify the hypothesis that enteric short-chain fatty acids may be a potential environmental trigger in some forms of ASD. Novel collaborative developments in systems biology, particularly examining the role of the micro-biome and its effects on host metabolism, immune and mitochondrial function, and gene expression, hold great promise in ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Even beneficial metabolites such as short-chain fatty acids may exert neurotoxicity.”
From The Gut Microbiome and the Brain (2014) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Antibiotics in early life alter the murine colonic microbiome and adiposity
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. (2012) · Nature · doi:10.1038/nature11400 · Cited by 1,613
Carlezon, W. A., Duman, R. S., & Nestler, E. J. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,382
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 940
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
Atladóttir, H. Ó., Thorsen, P., Østergaard, L., Schendel, D. E., Lemcke, S., Abdallah, M., & Parner, E. T. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1006-y · Cited by 916
Research works printed but not linked: 6
- MacFabe DF, 2012, Microb Ecol Health Dis., 23, 19260
- Zarate G, 2004, Methods Mol Biol., 268, 423
- Conn AR, 1983, Am J Physiol, 245, E253
- Frick LR, 2013, Clin Dev Immunol., 608654
- Gottschall E, 1994, Breaking the vicious cycle: intestinal health through diet.
- Diamond J, 1997, Guns, germs, and steel.
Cited by
Sorted by citations
Items 101–131 of 131
Mehta, R., Bhandari, R., & Kuhad, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00811-7 · Cited by 3
de SOUZA, M. M., Rodrigues, J. V. S., GONÇALVES, M. E. C., ROSSATO, A. C. P., Stein, M. C. R. V., Poli, M. C. F., Theodoro, L. H., & Nakamune, A. C. D. M. S. (2021) · Revista de Odontologia da UNESP · doi:10.1590/1807-2577.05721 · Cited by 3
Prevention of neurodegenerative disorders by nutraceuticals
Pistollato, F., & Sachana, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00002-1 · Cited by 3
Recent Advances in Neurodegeneration
Borreca, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.71995 · Cited by 3
Salem, H. A., Rizk, N. I., AbdelSalam, M. H., Ahmed, R., Atteia, H. H., Hamdan, A. M. E., Alghamdi, A. A., Alghusn, M. A., Alatawi, R. A., Atallah, R. A., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1728908 · Cited by 2
Bacha, A. G. B., Alonazi, M. A., Aljehani, E. M., Alabdali, A. N., Bhat, R. S., Almuayrifi, M., Horchani, H., & El-Ansary, A. K. (2024) · International Journal of Pharmacology · doi:10.3923/ijp.2024.1479.1487 · Cited by 2
The need for training dentists for dental care for people with autism spectrum disorder
Amaral, L. D., Azevedo, T. D. P. L., Moreira, F. D. C. L., de Lima, A. D. A., & Bezerra, A. C. B. (2021) · Revista Odontológica do Brasil Central · doi:10.36065/robrac.v30i89.1555 · Cited by 2
David, M. M., Tataru, C. A., Daniels, J., Schwartz, J. N., Keating, J., Hampton‐Marcell, J., Gottel, N., Gilbert, J. A., & Wall, D. P. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/319236 · Cited by 2
A Copula Type-Model for Examining the Role of Microbiome as a Potential Tool in Diagnosis
Calderín–Ojeda, E., López–Campos, G., & Gómez–Déniz, E. (2022) · Mathematical Problems in Engineering · doi:10.1155/2022/8033806 · Cited by 1
The Enigmatic Gut-Brain-Immune Trio in Brain and Behavior Disorders
Mythri, R. B. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch019 · Cited by 1
Zhou, A., Guo, C., Abdelsattar, M. M., Musa, A. R., Biks, M., Musa, A. A., Rahman, S., Aleli, A. T., Zhong, P., Zhang, J. X., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70114 · Cited by 1
[Anatomy of the external saphenous vein].
Payen, B. (1985) · PubMed · Cited by 4
Prevention of Neurodegenerative Disorders by Nutraceuticals
Pistollato, F., & Sachana, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00002-4 · Cited by 1
The Role of the Human Microbiomein the Development of Pain Syndromes
Усова, Н. Н., & Sa, L. (2021) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2021.11.1.031 · Cited by 1
Inflammation, stress, and gut-brain axis as therapeutic targets in bipolar disorder
Vaccariello, E. D., & Nguyen, T. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821398-8.00008-4 · Cited by 1
GUT in FOCUS Symposium NOBEL FORUM, Karolinska Institutet
(2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.28480
Energy metabolism and autism: the ameliorative potential of carnosine and agmatine
Hipkiss, A. R. (2018) · Neurological Disorders and Therapeutics · doi:10.15761/ndt.1000135
(2020) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2020.e271
Gut microbiota and brain function and pathophysiology
Duttaroy, A. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822405-2.00014-1
Taleghanie, B. K., Abedi, S., Jafari, A., & Hedayati, M. (2021) · Journal of Current Biomedical Reports · doi:10.52547/10.52547/jcbior.2.3.90
De la aldea de Potemkim a la democracia virtual en Rusia
Cardona, P. B. (2004) · Claves de razón práctica
Gut–brain communication: a novel application of probiotics
Das, S., Undhad, T. J., & Hati, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00017-0
Investigation of Carnitine Levels in some Biological Fluids
Alzamily, A. A., Hameedi, A. J., & AL-Kafagi, A. A. (2024) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v8i1.41
Fowler, S. P., Gimeno, D., Swartz, M. D., Granados, P. S., Heilbrun, L. P., & Palmer, R. F. (2024) · Nutrients · doi:10.3390/nu16050676
Probiotics and the Microbiota-Gut-Brain Axis
Asalipiseheh, A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006494
Динамика состава кишечного микробиома у пациентов с постинсультным болевым синдромом
Усова, Н. Н., Стома, И. О., Ковалев, А. А., Осипкина, О. В., Шафорост, А. С., & Зятьков, А. А. (2025) · Неврология и нейрохирургия Восточная Европа · doi:10.34883/pi.2025.15.4.044
Al‐Beltagi, M. (2026) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v15.i2.118495 · Cited by 1
Rodrigues, J. V. S., Takeshita, W. M., Garcia, R. A., Aranega, A. M., de Molon, R. S., & Theodoro, L. H. (2026) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2026ao2383
Japaridze, N. J., Khomasuridze, P., Zhvania, M. G., Lobzhanidze, G., Tizabi, Y., Rzayev, F., Gasimov, E. K., & Pochkhidze, N. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150529
Metadata
- Authors
- Macfabe, D.
- Affiliations
- Western University (CA)
- Corresponding author
- Macfabe, Derrick
- Venue
- Global Advances in Health and Medicine
- Publisher
- SAGE Publications
- Published
- 2013-11
- Volume
- 2
- Issue
- 6
- Pages
- 52-66
- ISSN
- 2164-9561 (ISSN-L)
- 2164-957X
- PMC
- PMC3865378
- OpenAlex
- W1970972871
- Cited by
- 131
- References
- 96
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 12 · 2023: 2 · 2022: 8 · 2021: 18 · 2020: 8 · 2019: 11 · 2018: 17 · 2017: 11 · 2016: 9 · 2015: 10 · 2014: 11 · 2013: 1
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Global Advances in Health and Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Autism Research Institute
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, gut microbiota, propionic acid, short-chain fatty acids, mitochondrial dysfunction, oxidative stress, neuroinflammation, glutathione depletion, acylcarnitines, phospholipids, neurodevelopmental disorders, environmental triggers, antibiotic exposure, gastrointestinal symptoms, neurobehavioral phenotype, systems biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review